483 Recipharm Pharmaservices Private May 2018

483 Recipharm Pharmaservices Private May 2018

Lata Mathew FDA, Daniel Obrzut FDA$119.00 - Available Now

FDA investigators audited the Recipharm Pharmaservices Private - Bangalore, India facility and issued inspectional observations (via FDA 483) on 11 May 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 11 May 2018
  • Location: Bangalore, India
  • FEI: 3009150119
Add To Cart